altered in Huntington's chorea. Further observations of HGH release may therefore be of value in its diagnosis.
The biochemistry of Huntington's chorea has been extensively studied (for reviews see Bruyn, 1968; Barbeau, 1973) . The occurrence in many patients with this disorder of weight loss and excessive sweating has been attributed to altered hypothalamic function (Bruyn, 1973) . Neuropathological evidence of hypothalamic involvement in Huntington's chorea has been demonstrated (Bruyn, 1968 (Bruyn, , 1973 Klintworth, 1973) . In addition, altered growth hormone (HGH) release has been reported in patients with Huntington's chorea (Podolsky and Leopold, 1973) . We now present further evidence of abnormalities of HGH release: we have found that patients with Huntington's chorea showed a markedly different HGH response to insulin induced hypoglycaemia compared with controls.
METHODS
Glucose tolerance tests SUBJECTS Five unrelated patients (one male, four female) with Huntington's chorea were studied. were in the normal range and no significant difference between the two groups was found during the investigation (Fig. 1 ).
Insulin tolerance tests SUBJECTS Twelve patients (three male, nine female) with Huntington's chorea were studied; the diagnostic criteria were as before. Symptoms had been present for a mean of 10 years (range two to 12). Their mean age was 44 years (25-63), and mean weight was 56 kg (35-73). Ten control subjects (five male, five female) were also studied. They had a mean age of 42 years (32-57) and mean weight of 57 kg (41-74). The groups were matched as closely as possible and there was no significant difference between their weights. PROCEDURE All subjects were examined under conditions similar to the first investigation. One patient had never received phenothiazines or other drugs for chorea. All other patients had been without any drugs for at least 72 hours. Blood was taken from a venous cannula placed in an antecubital vein. Two resting samples of blood (10 ml) were taken as before. Soluble insulin (0.1 units/kg body wt) was then injected intravenously via the cannula and blood samples were taken regularly for 75 minutes. In all investigations, blood samples were taken at 10, 20, 30, 45, 60 , and 75 minutes after insulin injection. In addition, five patients and three controls had extra samples taken at 25, 35, 40, and 50 minutes. The samples were analysed for glucose and immunoreactive insulin as described above; HGH was analysed by a radioimmunoassay technique (Sorin Gruppo Radiochimica, Italy; Morgan, 1966) . Significances of difference were examined as previously. RESULTS Blood glucose (Fig. 2 ) Resting values were normal in both groups and during the investigation hypoglycaemia developed. The lowest concentrations were observed 25 minutes after injection of insulin and there was no significant difference between the groups at any time.
Plasma insulin Resting values were similar in patients and controls (9 ,uU/ml, controls; 10 ,uU/ml, patients). After injection of soluble insulin, plasma insulin rose to levels of over 300 pU/ml in both groups at the time of the next sample, 10 minutes later.
Plasma HGH (Fig. 3 (Bruyn, 1968; Earle, 1973; Klintworth, 1973 (Forrest, 1957; Podolsky et al., 1972) . However, the results of the glucose tolerance tests were also similar to control studies and we found no evidence of altered insulin release. We have, therefore, not substantiated the findings of Podolsky and his co-workers. Growth hormone release has also been studied by giving L-dopa to patients with Huntington's chorea and abnormalities have been reported (Podolsky and Leopold, 1973) . It has been suggested that studies of growth hormone release after giving L-dopa might act as a test for patients' relatives in whom the disease is latent and has yet to develop. It is possible, however, that L-dopa may provoke chorea in such individuals (Klawans et al., 1972) . We therefore did not feel it justifiable to investigate growth hormone release in this way and have used a different stimulus, insulin induced hypoglycaemia, which is known to cause rapid release of growth hormone (Roth et al., 1963) .
During the insulin test the fall in blood glucose was similar in both groups and the lowest concentrations were observed at the same time after injection of insulin. The resting levels of HGH of both groups were within the normal range expected, but there was a marked difference in the timing of the growth hormone increase during the investigations (Fig. 3) as the patients had an earlier rise. The mean values of the HGH in the patients were significantly higher at the 30 and 35 minute points (P <0.001; P<0.02). These observations suggest an alteration in the threshold for HGH release by the hypothalamus, perhaps due to altered dopaminergic sensitivity. It is not, however, possible to relate this to the reported pathological changes. The hypothalamic gliosis previously shown in patients with Huntington's chorea (Bruyn, 1968) could result in a reduction in HGH release due to a failure of normal production of growth hormone releasing factor, but we have no definite evidence of this. An alternative explanation of these findings is that the altered threshold level is a result of hypersensitivity to drugs such as phenothiazines (Klawans, 1970 Our observations have shown that there is an alteration in the pattern of growth hormone release in patients with Huntington's chorea using a standard test of injection of insulin. Our results would be in keeping with the suggestion that there is abnormal hypothalamic activity in Huntington's chorea and the emaciation frequently observed in patients with this disorder (Bruyn, 1973) 
